Therefore, controversy exists regarding the specific effect of the MELK inhibitor and the role of MELK in cancer. In spite of this, we found that MELK inhibition could suppress GBM cell growth in vitro and in vivo in our study. The gene discussed is MELK; the disease is glioblastoma.